More from Mitesh Patel
New follower can go through my old tweets through this link to learn about my trading style.
https://t.co/YqesIdZDQ2\u2026
— Naveen sharma (@learner_naveen) June 14, 2021
Here is the link to the book aka copiled tweets of @Mitesh_Engr sir @_GauravVashisth @ITRADE191 Sir
Anyone can download and use it for free.
Pvt LTD : 25% tax
You can withdraw fund in form of salary and dividend only. Double taxation if withdraw after completion of financial year.
Partnership firm : 35% tax
Funds u can withdraw anytime. No double taxation even after completion of financial year.
Discussed with CA.
If any CA has more information they can update here.
I am moving ( principal capital) to partnership firm to avoid double taxation.
Only drawback is you have to pay more 10% tax but funds will remain on your name only and no double taxation in future. You can buy properties etc on your name.
You can withdraw fund in form of salary and dividend only. Double taxation if withdraw after completion of financial year.
Partnership firm : 35% tax
Funds u can withdraw anytime. No double taxation even after completion of financial year.
Discussed with CA.
1. Make a Pvt Ltd Company.
— Aditya Todmal (@AdityaTodmal) March 1, 2022
Form a company with family members and trade under it. The family members should be directors of the company. Will explain why later.
Why form a company?
You will only need to pay 25% flat tax. Individuals have to pay 30% tax above 10 lakh profits.
If any CA has more information they can update here.
I am moving ( principal capital) to partnership firm to avoid double taxation.
Only drawback is you have to pay more 10% tax but funds will remain on your name only and no double taxation in future. You can buy properties etc on your name.
You May Also Like
Keep dwelling on this:
Further Examination of the Motif near PRRA Reveals Close Structural Similarity to the SEB Superantigen as well as Sequence Similarities to Neurotoxins and a Viral SAg.
The insertion PRRA together with 7 sequentially preceding residues & succeeding R685 (conserved in β-CoVs) form a motif, Y674QTQTNSPRRAR685, homologous to those of neurotoxins from Ophiophagus (cobra) and Bungarus genera, as well as neurotoxin-like regions from three RABV strains
(20) (Fig. 2D). We further noticed that the same segment bears close similarity to the HIV-1 glycoprotein gp120 SAg motif F164 to V174.
https://t.co/EwwJOSa8RK
In (B), the segment S680PPRAR685 including the PRRA insert and highly conserved cleavage site *R685* is shown in van der Waals representation (black labels) and nearby CDR residues of the TCRVβ domain are labeled in blue/white
https://t.co/BsY8BAIzDa
Sequence Identity %
https://t.co/BsY8BAIzDa
Y674 - QTQTNSPRRA - R685
Similar to neurotoxins from Ophiophagus (cobra) & Bungarus genera & neurotoxin-like regions from three RABV strains
T678 - NSPRRA- R685
Superantigenic core, consistently aligned against bacterial or viral SAgs
Further Examination of the Motif near PRRA Reveals Close Structural Similarity to the SEB Superantigen as well as Sequence Similarities to Neurotoxins and a Viral SAg.
The insertion PRRA together with 7 sequentially preceding residues & succeeding R685 (conserved in β-CoVs) form a motif, Y674QTQTNSPRRAR685, homologous to those of neurotoxins from Ophiophagus (cobra) and Bungarus genera, as well as neurotoxin-like regions from three RABV strains
(20) (Fig. 2D). We further noticed that the same segment bears close similarity to the HIV-1 glycoprotein gp120 SAg motif F164 to V174.
https://t.co/EwwJOSa8RK

In (B), the segment S680PPRAR685 including the PRRA insert and highly conserved cleavage site *R685* is shown in van der Waals representation (black labels) and nearby CDR residues of the TCRVβ domain are labeled in blue/white
https://t.co/BsY8BAIzDa

Sequence Identity %
https://t.co/BsY8BAIzDa
Y674 - QTQTNSPRRA - R685
Similar to neurotoxins from Ophiophagus (cobra) & Bungarus genera & neurotoxin-like regions from three RABV strains
T678 - NSPRRA- R685
Superantigenic core, consistently aligned against bacterial or viral SAgs
